What You Should Know:
- Just weeks after acquiring MIM Software, a leader in medical imaging analysis and AI solutions, GE HealthCare strengthens its commitment to improving cancer care through a deeper collaboration with Elekta, a leader in precision radiation oncology.
- The strategic partnership aims to revolutionize radiation therapy workflows and ultimately benefit both patients and healthcare providers.
Addressing Challenges in Radiation Therapy
Nearly two-thirds of
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
VieCure Streamlines Cancer Care with Integrated E-Prescribing and Medication Management
What You Should Know:
- VieCure, a leading cancer care company, announced today that it's integrating DrFirst's e-prescribing and medication management solutions into its clinical decision support system.
- VieCure is a well-established point-of-care intelligence system specifically designed for community oncologists. Utilizing artificial intelligence (AI), patient data, and a comprehensive oncology knowledge base, VieCure generates personalized treatment plans for cancer
Read More
American Cancer Society, Color Health Expand Cancer Care Program for Employers and Unions
What You Should Know:
- The American Cancer Society (ACS) and Color Health announced today a significant expansion of their existing program, creating a first-of-its-kind comprehensive cancer solution for employers and labor unions. This enhanced program goes beyond screening and prevention to support employees and members throughout all stages of the cancer journey.
- The expanded program builds upon the existing collaboration between ACS and Color Health, which has already provided
Read More
MUSC Hollings Cancer Center and Flatiron Health Partner to Deliver Advanced Cancer Care
What You Should Know:
- The Medical University of South Carolina (MUSC) Hollings Cancer Center and Flatiron Health, a leading oncology-focused healthtech company, today announced a collaboration to bring Flatiron Assist™ to MUSC's oncology care clinicians.
- The strategic collaboration equips clinicians at MUSC Hollings Cancer Center with Flatiron Assist, a unique clinical decision support platform designed specifically for oncology. Flatiron Assist prioritizes the latest
Read More
Thyme Care Launches VBC Platform w/ 400+ Oncologists
What You Should Know:
- Thyme Care, a leader in value-based cancer care, has launched Thyme Care Oncology Partners (TCOP), a dedicated platform designed to support oncology practices in the transition to value-based care models.
- Through partnerships with payers and providers, Thyme Care's TCOP platform fosters collaboration and prioritizes patient-centric care while reducing costs. This innovative approach positions Thyme Care as a leader in shaping the future of value-based cancer
Read More
Oracle-Backed Cancer Startup Project Ronin Shutters
What You Should Know:
- Project Ronin, a software startup focused on applying AI to improve cancer care, announced its closure, Bloomberg first reports.
- The company, co-founded by Oracle co-founder and chairman Larry Ellison, cited financial difficulties as the primary reason for the shutdown.
Project Ronin Background
Founded in 2018, Ronin aimed to develop solutions that could rapidly analyze and interpret data within electronic health records systems used by hospitals.
Read More
Belong.Life Launches Conversational AI Cancer Mentor
What You Should Know:
Belong.Life, a leading global provider of AI-powered patient education and support solutions, has unveiled the BelongAI Dave - Cancer Mentor app to bring the most advanced and comprehensive cancer support technology to patients and caregivers around the world.The new solution marks a significant step forward in personalized cancer support, by providing patients with a proactive and comprehensive conversational-AI solution for managing their journey
Read More
6 Ways AI is Impacting Cancer Diagnosis, Treatment and Patient Outcomes in 2024
Artificial intelligence (AI) technology is set to transform the field of diagnostics, similar to how X-rays and genetic tests revolutionized healthcare in the past. Reshaping routine diagnostic procedures and treatment decisions and propelling pharmaceutical and research domains into new realms, AI offers significant benefits to clinicians, healthcare systems, researchers, and, most importantly, patients. This is particularly evident in cancer diagnosis and treatment across six key areas:
1.
Read More
ConcertAI Acquires CancerLinQ to Expand Real-World Data and AI Solutions for Cancer Care
What You Should Know:
- ConcertAI, a developer of AI-powered healthcare solutions, announced today the acquisition of CancerLinQ, a subsidiary of the American Society of Clinical Oncology (ASCO).
- This strategic move will significantly enhance and expand CancerLinQ's capabilities, unlocking the potential of real-world data and next-generation AI to revolutionize cancer care and accelerate clinical research.
CancerLinQ Background
CancerLinQ represents one of the largest oncology
Read More
Syapse and FDA OCE Collaborate to Advance Real-World Evidence in Oncology
What You Should Know:
- Syapse®, a leading real-world evidence (RWE) company dedicated to extinguishing the fear and burden of serious diseases, and the FDA Oncology Center of Excellence (OCE) today announced the renewal of their four-year collaboration agreement.
- This expanded strategic partnership aims to collaboratively develop and implement research projects that advance the use of real-world data (RWD) and explore the potential of RWE to inform regulatory decisions in
Read More
